메뉴 건너뛰기




Volumn 9, Issue 1, 2015, Pages 309-322

Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies

Author keywords

Bortezomib; Dipyridamole; ER stress; GSH ROS; Hematologic malignancies; JAK2; Pro survival pathways

Indexed keywords

BORTEZOMIB; CYCLOHEXIMIDE; DIPYRIDAMOLE; GLUTATHIONE; JANUS KINASE 2; PROTEASOME; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; TUMOR PROTEIN;

EID: 84920483656     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.08.010     Document Type: Article
Times cited : (16)

References (41)
  • 1
    • 84860468095 scopus 로고    scopus 로고
    • Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling
    • Appenzeller-Herzog C., Hall M.N. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 2012, 22:274-282.
    • (2012) Trends Cell Biol. , vol.22 , pp. 274-282
    • Appenzeller-Herzog, C.1    Hall, M.N.2
  • 5
    • 79951702955 scopus 로고    scopus 로고
    • Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives
    • Chen D., Frezza M., Schmitt S., Kanwar J., Dou Q.P. Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr. Cancer Drug Targets 2011, 11:239-253.
    • (2011) Curr. Cancer Drug Targets , vol.11 , pp. 239-253
    • Chen, D.1    Frezza, M.2    Schmitt, S.3    Kanwar, J.4    Dou, Q.P.5
  • 7
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
    • Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme. Regul. 1984, 22:27-55.
    • (1984) Adv. Enzyme. Regul. , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 8
    • 84857067025 scopus 로고    scopus 로고
    • Molecular pathways: BCR-ABL
    • Cilloni D., Saglio G. Molecular pathways: BCR-ABL. Clin. Cancer Res. 2012, 18:930-937.
    • (2012) Clin. Cancer Res. , vol.18 , pp. 930-937
    • Cilloni, D.1    Saglio, G.2
  • 9
    • 0028332080 scopus 로고
    • The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance
    • Clarke W.R., Uezono S., Chambers A., Doepfner P. The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance. Pulm. Pharmacol. 1994, 7:81-89.
    • (1994) Pulm. Pharmacol. , vol.7 , pp. 81-89
    • Clarke, W.R.1    Uezono, S.2    Chambers, A.3    Doepfner, P.4
  • 11
    • 33749252583 scopus 로고    scopus 로고
    • Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
    • Eckelman B.P., Salvesen G.S., Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006, 7:988-994.
    • (2006) EMBO Rep. , vol.7 , pp. 988-994
    • Eckelman, B.P.1    Salvesen, G.S.2    Scott, F.L.3
  • 12
    • 44449102684 scopus 로고    scopus 로고
    • Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole
    • Goda A.E., Yoshida T., Horinaka M., Yasuda T., Shiraishi T., Wakada M., Sakai T. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole. Oncogene 2008, 27:3435-3445.
    • (2008) Oncogene , vol.27 , pp. 3435-3445
    • Goda, A.E.1    Yoshida, T.2    Horinaka, M.3    Yasuda, T.4    Shiraishi, T.5    Wakada, M.6    Sakai, T.7
  • 14
    • 84861567265 scopus 로고    scopus 로고
    • Redox signaling loops in the unfolded protein response
    • Higa A., Chevet E. Redox signaling loops in the unfolded protein response. Cell. Signal. 2012, 24:1548-1555.
    • (2012) Cell. Signal. , vol.24 , pp. 1548-1555
    • Higa, A.1    Chevet, E.2
  • 15
    • 0035925098 scopus 로고    scopus 로고
    • Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects
    • Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J.Natl. Cancer Inst. 2001, 93:266-276.
    • (2001) J.Natl. Cancer Inst. , vol.93 , pp. 266-276
    • Hockel, M.1    Vaupel, P.2
  • 17
    • 0022900617 scopus 로고
    • Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates
    • Kennedy D.G., Van den Berg H.W., Clarke R., Murphy R.F. Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates. Biochem. Pharmacol. 1986, 35:3053-3056.
    • (1986) Biochem. Pharmacol. , vol.35 , pp. 3053-3056
    • Kennedy, D.G.1    Van den Berg, H.W.2    Clarke, R.3    Murphy, R.F.4
  • 19
    • 83255192206 scopus 로고    scopus 로고
    • BID binds to replication protein A and stimulates ATR function following replicative stress
    • Liu Y., Vaithiyalingam S., Shi Q., Chazin W.J., Zinkel S.S. BID binds to replication protein A and stimulates ATR function following replicative stress. Mol. Cell Biol. 2011, 31:4298-4309.
    • (2011) Mol. Cell Biol. , vol.31 , pp. 4298-4309
    • Liu, Y.1    Vaithiyalingam, S.2    Shi, Q.3    Chazin, W.J.4    Zinkel, S.S.5
  • 20
    • 53049083867 scopus 로고    scopus 로고
    • Mechanisms of proteasome inhibitor action and resistance in cancer
    • McConkey D.J., Zhu K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug. Resist. Updat. 2008, 11:164-179.
    • (2008) Drug. Resist. Updat. , vol.11 , pp. 164-179
    • McConkey, D.J.1    Zhu, K.2
  • 22
    • 0031614916 scopus 로고    scopus 로고
    • Simultaneous measurement of cell cycle and apoptotic cell death
    • Moore A., Donahue C.J., Bauer K.D., Mather J.P. Simultaneous measurement of cell cycle and apoptotic cell death. Methods Cell Biol. 1998, 57:265-278.
    • (1998) Methods Cell Biol. , vol.57 , pp. 265-278
    • Moore, A.1    Donahue, C.J.2    Bauer, K.D.3    Mather, J.P.4
  • 23
    • 18244432009 scopus 로고    scopus 로고
    • Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
    • Neubauer H., Cumano A., Müller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998, 93:397-409.
    • (1998) Cell , vol.93 , pp. 397-409
    • Neubauer, H.1    Cumano, A.2    Müller, M.3    Wu, H.4    Huffstadt, U.5    Pfeffer, K.6
  • 24
    • 0009975004 scopus 로고    scopus 로고
    • Mutation of Bcl-2 family proteins in Cancer
    • Packham G. Mutation of Bcl-2 family proteins in Cancer. Apoptosis 1998, 3:75-82.
    • (1998) Apoptosis , vol.3 , pp. 75-82
    • Packham, G.1
  • 25
    • 30144442233 scopus 로고    scopus 로고
    • The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
    • Pérez-Galán P., Roué G., Villamor N., Montserrat E., Campo E., Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006, 107:257-264.
    • (2006) Blood , vol.107 , pp. 257-264
    • Pérez-Galán, P.1    Roué, G.2    Villamor, N.3    Montserrat, E.4    Campo, E.5    Colomer, D.6
  • 26
    • 33646595660 scopus 로고    scopus 로고
    • Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling
    • Piwocka K., Vejda S., Cotter T.G., O'Sullivan G.C., McKenna S.L. Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling. Blood 2006, 107:4003-4010.
    • (2006) Blood , vol.107 , pp. 4003-4010
    • Piwocka, K.1    Vejda, S.2    Cotter, T.G.3    O'Sullivan, G.C.4    McKenna, S.L.5
  • 27
    • 77956108780 scopus 로고    scopus 로고
    • Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies
    • Reddy N., Czuczman M.S. Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies. Ann. Oncol. 2010, 21:1756-1764.
    • (2010) Ann. Oncol. , vol.21 , pp. 1756-1764
    • Reddy, N.1    Czuczman, M.S.2
  • 28
    • 42049083776 scopus 로고    scopus 로고
    • JAK2 activation in myeloproliferative neoplasms: a potential role for heterodimeric receptors
    • Reuther G.W. JAK2 activation in myeloproliferative neoplasms: a potential role for heterodimeric receptors. Cell Cycle 2008, 7:714-719.
    • (2008) Cell Cycle , vol.7 , pp. 714-719
    • Reuther, G.W.1
  • 29
    • 2442600292 scopus 로고    scopus 로고
    • Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells invitro
    • Rodrigues M., Barbosa F., Perussi J.R. Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells invitro. Braz. J. Med. Biol. Res. 2004, 37:591-599.
    • (2004) Braz. J. Med. Biol. Res. , vol.37 , pp. 591-599
    • Rodrigues, M.1    Barbosa, F.2    Perussi, J.R.3
  • 30
    • 0015526135 scopus 로고
    • Cyclic 3'5'-adenosine monophosphate in human blood platelets: regulatory role of cyclic AMP in platelet function
    • Salzman E.W., Kensler P.C., Levine L. Cyclic 3'5'-adenosine monophosphate in human blood platelets: regulatory role of cyclic AMP in platelet function. Ann. N. Y. Acad. Sci. 1972, 201:61-71.
    • (1972) Ann. N. Y. Acad. Sci. , vol.201 , pp. 61-71
    • Salzman, E.W.1    Kensler, P.C.2    Levine, L.3
  • 31
    • 0027363244 scopus 로고
    • Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor
    • Sato S., Kohno K., Hidaka K., Hisatsugu T., Kuwano M., Komiyama S. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor. Anticancer. Drug. Des. 1993, 8:289-297.
    • (1993) Anticancer. Drug. Des. , vol.8 , pp. 289-297
    • Sato, S.1    Kohno, K.2    Hidaka, K.3    Hisatsugu, T.4    Kuwano, M.5    Komiyama, S.6
  • 33
    • 79951832885 scopus 로고    scopus 로고
    • Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia
    • Tanturli M., Giuntoli S., Barbetti V., Rovida E., Dello Sbarba P. Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. PLoS One 2011, 6:e17008.
    • (2011) PLoS One , vol.6 , pp. e17008
    • Tanturli, M.1    Giuntoli, S.2    Barbetti, V.3    Rovida, E.4    Dello Sbarba, P.5
  • 34
    • 33846903320 scopus 로고    scopus 로고
    • Deregulation of apoptosis in acute myeloid leukemia
    • Testa U., Riccioni R. Deregulation of apoptosis in acute myeloid leukemia. Haematologica 2007, 92:81-94.
    • (2007) Haematologica , vol.92 , pp. 81-94
    • Testa, U.1    Riccioni, R.2
  • 36
    • 0036233985 scopus 로고    scopus 로고
    • Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1
    • Ungureanu D., Saharinen P., Junttila I., Hilton D.J., Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell Biol. 2002, 22:3316-3326.
    • (2002) Mol. Cell Biol. , vol.22 , pp. 3316-3326
    • Ungureanu, D.1    Saharinen, P.2    Junttila, I.3    Hilton, D.J.4    Silvennoinen, O.5
  • 38
    • 0028172868 scopus 로고
    • P53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
    • Wattel E., Preudhomme C., Hecquet B., Vanrumbeke M., Quesnel B., Dervite I., Morel P., Fenaux P. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 1994, 84:3148-3157.
    • (1994) Blood , vol.84 , pp. 3148-3157
    • Wattel, E.1    Preudhomme, C.2    Hecquet, B.3    Vanrumbeke, M.4    Quesnel, B.5    Dervite, I.6    Morel, P.7    Fenaux, P.8
  • 40
    • 0027960678 scopus 로고
    • Kinetic analysis of the intracellular conjugation of monochlorobimane by IC-21 murine macrophage glutathione-S-transferase
    • Young P.R., ConnorsWhite A.L., Dzido G.A. Kinetic analysis of the intracellular conjugation of monochlorobimane by IC-21 murine macrophage glutathione-S-transferase. Biochim. Biophys. Acta. 1994, 1201:461-465.
    • (1994) Biochim. Biophys. Acta. , vol.1201 , pp. 461-465
    • Young, P.R.1    ConnorsWhite, A.L.2    Dzido, G.A.3
  • 41
    • 84872264689 scopus 로고    scopus 로고
    • JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
    • Zhao W., Du Y., Ho W.T., Fu X., Zhao Z.J. JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines. Exp. Hematol. Oncol. 2012, 1:15.
    • (2012) Exp. Hematol. Oncol. , vol.1 , pp. 15
    • Zhao, W.1    Du, Y.2    Ho, W.T.3    Fu, X.4    Zhao, Z.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.